10x Genomics, Inc. (TXG) has a consensus analyst rating of Hold, based on 22 analysts covering the stock. Of those, 10 recommend buying, 11 recommend holding, and 1 recommend selling.
The analyst consensus price target for TXG is $21.00, representing a -15.3% downside from the current price of $24.8. Price targets range from a low of $17.00 to a high of $25.00.
